sable bio
SableBio is an innovative company focused on transforming drug safety assessment through AI-powered platforms. Their mission is to help scientists make faster, systematic, and up-to-date safety decisions to better understand and mitigate toxicology risks in drug development.
Industries
Nr. of Employees
small (1-50)
Products
Target safety intelligence platform
A software platform that aggregates multimodal safety data, applies AI-driven analysis and produces interactive, up‑to‑date safety reports for drug targets.
Target safety intelligence platform
A software platform that aggregates multimodal safety data, applies AI-driven analysis and produces interactive, up‑to‑date safety reports for drug targets.
Services
Service to evaluate theoretical safety risks associated with an individual drug target during discovery.
Comparative safety analysis across multiple targets to prioritise programs when manual review is impractical.
Assessment to anticipate potential safety risks for targets developed by third parties to inform commercial decisions.
Live demos of the safety intelligence platform to show capabilities and workflows.
Service to evaluate theoretical safety risks associated with an individual drug target during discovery.
Comparative safety analysis across multiple targets to prioritise programs when manual review is impractical.
Assessment to anticipate potential safety risks for targets developed by third parties to inform commercial decisions.
Live demos of the safety intelligence platform to show capabilities and workflows.
Expertise Areas
- Target safety assessment
- Toxicology data integration
- Drug target risk prioritization
- Safety due diligence for targets
Key Technologies
- AI / machine learning for toxicology
- Natural language processing (text mining)
- Multi‑modal data integration
- Risk‑scoring and weighting algorithms